Literature DB >> 7847693

Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease.

R A Nixon1, K I Saito, F Grynspan, W R Griffin, S Katayama, T Honda, P S Mohan, T B Shea, M Beermann.   

Abstract

Calpains (CANPs) are a family of calcium-dependent cysteine proteases under complex cellular regulation. By making selective limited proteolytic cleavages, they activate or alter the regulation of certain enzymes, including key protein kinases and phosphatases, and induce specific cytoskeletal rearrangements, accounting for their suspected involvement in intracellular signaling, vesicular trafficking, and structural stabilization. Calpain activity has been implicated in various aging phenomena, including cataract formation and erythrocyte senescence. Abnormal activation of the large stores of latent calpain in neurons induces cell injury and is believed to underlie neurodegeneration in excitotoxicity, Wallerian degeneration, and certain other neuropathologic states involving abnormal calcium influx. In Alzheimer's disease, we found the ratio of activated calpain I to its latent precursor isoform in neocortex to be threefold higher than that in normal individuals and those with Huntington's or Parkinson's disease. Immunoreactivity toward calpastatin, the endogenous inhibitor of calpain, was also markedly reduced in layers II-V of the neocortex in Alzheimer's disease. The excessive calpain system activation suggested by these findings represents a potential molecular basis for synaptic loss and neuronal cell death in the brain in Alzheimer's disease given the known destructive actions of calpain I and its preferential neuronal and synaptic localization. In surviving cells, persistent calpain activation may also contribute to neurofibrillary pathology and abnormal amyloid precursor protein trafficking/processing through its known actions on protein kinases and the membrane skeleton. The degree of abnormal calpain activation in the brain in Alzheimer's disease strongly correlated with the extent of decline in levels of secreted amyloid precursor protein in brain. Cytoskeletal proteins that are normally good calpain substrates become relatively calpain resistant when they are hyperphosphorylated, which may contribute to their accumulation in neurofibrillary tangles. As a major effector of calcium signals, calpain activity may mirror disturbances in calcium homeostasis and mediate important pathologic consequences of such disturbances.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7847693     DOI: 10.1111/j.1749-6632.1994.tb44402.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  55 in total

1.  Changes in intracellular localization of calpastatin during calpain activation.

Authors:  R De Tullio; M Passalacqua; M Averna; F Salamino; E Melloni; S Pontremoli
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

2.  Changes in intracellular calpastatin localization are mediated by reversible phosphorylation.

Authors:  M Averna; R de Tullio; M Passalacqua; F Salamino; S Pontremoli; E Melloni
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

3.  Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.

Authors:  Eric M Blalock; James W Geddes; Kuey Chu Chen; Nada M Porter; William R Markesbery; Philip W Landfield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

4.  Caspase-dependent degradation of MDMx/MDM4 cell cycle regulatory protein in amyloid β-induced neuronal damage.

Authors:  Daniel J Colacurcio; Jacob W Zyskind; Kelly L Jordan-Sciutto; Cagla Akay Espinoza
Journal:  Neurosci Lett       Date:  2015-10-22       Impact factor: 3.046

Review 5.  ER calcium and Alzheimer's disease: in a state of flux.

Authors:  Mark P Mattson
Journal:  Sci Signal       Date:  2010-03-23       Impact factor: 8.192

Review 6.  Calpain and synaptic function.

Authors:  Hai-Yan Wu; David R Lynch
Journal:  Mol Neurobiol       Date:  2006-06       Impact factor: 5.590

7.  Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.

Authors:  Nana Jin; Xiaomin Yin; Jianlan Gu; Xinhua Zhang; Jianhua Shi; Wei Qian; Yuhua Ji; Maohong Cao; Xiaosong Gu; Fei Ding; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

8.  Characterization of the Ovarian Tumor Peptidome.

Authors:  Tao Liu; Karin D Rodland; Richard D Smith
Journal:  Vitam Horm       Date:  2018-02-22       Impact factor: 3.421

9.  Calpain 10 is required for cell viability and is decreased in the aging kidney.

Authors:  Marisa D Covington; David D Arrington; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

10.  Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease.

Authors:  Takahide Kaji; Barry Boland; Tatjana Odrljin; Panaiyur Mohan; Balapal S Basavarajappa; Corrinne Peterhoff; Anne Cataldo; Anna Rudnicki; Niranjana Amin; Bing Sheng Li; Harish C Pant; Basalingappa L Hungund; Ottavio Arancio; Ralph A Nixon
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.